Intrexon Corporation has received $-0.23 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 5 Financial Advisor in the Stock Trading Firms. Among 5 Analysts, Bottom line EPS Estimate for the current quarter is $-0.24 while the top line estimate is $-0.21 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -36.47%.
In the last quarter, Intrexon Corporation reported Annual Earnings of $-0.24. Based on the filings, last years Annual Earnings was, $-0.4. In the last Quarter, XON reported a surprise Earnings per Share of 0% . The consensus estimate for current quarter is $-0.23 and for the current fiscal year, the estimate is $-1.42. For the Next fiscal year, the estimate is $-0.82 based on the consensus.
Intrexon Corporation (NYSE:XON) : On Tuesday heightened volatility was witnessed in Intrexon Corporation (NYSE:XON) which led to swings in the share price. The stock opened for trading at $20.89 and hit $21.57 on the upside , eventually ending the session at $21.16, with a gain of 0.76% or 0.16 points. The heightened volatility saw the trading volume jump to 1,700,042 shares. The 52-week high of the share price is $39.854171 and the company has a market cap of $2,509 million. The 52-week low of the share price is at $20.41 .
Intrexon Corporation is a biotechnology company. It provides synthetic biology services. The Company designs and produces modular DNA control systems and applications for human therapeutics, protein production, industrial products, agricultural biotechnology, and animal sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery. Intrexon Corporation is based in Germantown, Maryland.